클래시스

214150KOSDAQ의료용 기기 제조업

55.3 / 100

Reference Date: 2026-04-13

Financial Score20.5 / 40

News Sentiment15.8 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Classys operates three main brands (CLASSYS, Cluederm, and ShringkRX/Skedum), focusing on aesthetic medical devices, consumables, and cosmetics. The company merged with IruDa in October 2024, enhancing its technological competitiveness in key EBD segments like micro-needle RF and laser. It generates revenue from over 80 countries, with medical devices and consumables accounting for 46% and 45% of sales, respectively.

Number of Employees

528people

Average Salary

65.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

26.87Industry Average 26.523.0Point

Higher than industry avg (caution)

PBR

6.41Industry Average 1.700.0Point

3.8x industry avg (risky)

ROE

26.28Industry Average 8.007.0Point

3.3x industry avg (excellent)

Debt Ratio

13.19Industry Average 10.952.0Point

Higher than industry avg (caution)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲36.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲38.0% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 27.2% (declining, 3yr)

Detailed News Sentiment

12 totalPositive 4Neutral 3Negative 0Average Sentiment Score 72.9

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 54,200Won52-week high 75,60052-week low 46,500

1-month return3.0Point

1m 0.56% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-04-01
Neutral정기주주총회결과2026-03-31
Neutral기업가치제고계획(자율공시)2026-03-31
Neutral금전대여결정2026-03-24
Neutral감사보고서제출2026-03-23